SAN DIEGO (November 25, 2008) - Awarepoint Corporation, a principal provider
of real-time location systems (RTLSs), today announced it has raised $13.3
million in a Series D round of venture capital financing led by Cardinal
Partners and joined by Venrock and existing investor Avalon Ventures. Funds
will be used as expansion to take advantage of the rapid demand for RTLS in
both domestic and international markets and to fuel Awarepoint's momentous
growth.



The Awarepoint Solution offers location, status and movement visibility of
both equipment and people, allowing for real-time remote monitoring of
critical resources. Awarepoint's RTLS Active Radio Frequency Identification
(RFID) platform includes a patented plug-in sensor mesh network, application
software, firmware, connectivity bridges, and multipurpose resource tags.
Awarepoint's solutions collect raw sensor data and transform that data into
high-value positioning, status and history information that is utilized to
add actionable awareness to a variety of healthcare and business
applications. Awarepoint is defining the emerging RTLS marketplace by
successfully addressing the factors critical to success: enterprise-wide
coverage, location accuracy, minimally invasive installs, interoperability
and a low risk business model.



"In today's uncertain economic environment, only the most extraordinary
growth companies will be financed, and Awarepoint is extraordinary. The
company has shown incredible growth in the last 18 months, and has the right
technology, intellectual property and product focus to succeed," said
Brandon Hull, managing partner at lead investor Cardinal Partners.
"Awarepoint is an ideal match with Cardinal Partners stated goal of funding
innovative technology/service companies which 'automate the broken processes
of healthcare'."



Venrock joins Cardinal Partners in this financing round. ""Awarepoint
addresses a difficult and expensive challenge that healthcare institutions
face every day," said Brian Ascher, general partner at Venrock. "We are
excited about the company's potential for growth and are looking forward to
working alongside the team to help drive its success."



While many companies are struggling today, Awarepoint's hard dollar return
on investment and hospital-friendly business model is actually fueling
tremendous growth. Awarepoint is able to offer a hard dollar return on
investment in areas hospitals struggle with daily - lost, stolen and
misplaced equipment; excessive equipment rentals, and capital budget
redundancies. Further, Awarepoint's interoperability, enterprise-wide
coverage, location accuracy and minimally invasive installs allow hospitals
to be ready to support more complex RTLS opportunities, including workflow
and business applications that involve patient and staff tracking, device
association and more.



"For hospital administrators, there's little worse than spending precious
capital resources on equipment they may not even need. With actionable
information regarding the location and status of the equipment they already
own, hospitals are able to reallocate existing capital budget dollars, or
simply reduce their capital equipment and rental expenses. Today's
challenging economic times make this more important than ever before," said
Jason Howe, CEO at Awarepoint.



"In view of the financial turmoil facing healthcare markets today, it is
especially rewarding to be able to partner with tier one investors like
Cardinal Partners and Venrock that truly understand the implications
technology can have on the bottom line. These firms not only add
significant expansion capital to Awarepoint, just as importantly, they add
true strategic vision and alliances that will undoubtedly help us build an
even stronger company. In addition, it's very validating to have our
existing investor, Avalon Ventures, participate fully in this round."



As a result of this financing round, Brandon Hull, managing partner at
Cardinal Partners and Brian Ascher, general partner at Venrock will join
Awarepoint's board of directors. The board also includes Jason Howe, CEO at
Awarepoint; Nico Nierenberg, Chairman of the Board and Chief Architect,
Actuate; Stephen L. Tomlin, Managing Member, Avalon Ventures; and Harold M.
Koenig, M.D., Chairman and President, The Annapolis Center for Science Based
Public Policy, retired Surgeon General of the Navy and Chief, Bureau of
Medicine and Surgery with the permanent rank of Vice Admiral.



About Awarepoint

Awarepoint's Active RFID technologies and real time location systems (RTLSs)
include its real time awareness platform, firmware, RFID tags, sensors, and
bridges. Awarepoint's technologies collect raw sensor data and transform
that data into high-value positioning information that can be used to add
location awareness to a variety of healthcare, manufacturing, security and
other applications. Requiring no hard wiring, Awarepoint's "plug and track"
network is a fully managed service, including hardware, software, remote
monitoring and maintenance. The company is headquartered in San Diego,
California and serves hospitals across the United States through a national
sales and operations workforce. Track us down at RFID Asset Tracking | Hospital Asset Tracking | Patient Flow




About Cardinal Partners

Since 1996, Cardinal Partners has been one of the leading venture capital
partnerships focused exclusively on healthcare investing. Cardinal is
committed to the belief that innovation and excellence in healthcare will
simultaneously improve the lives of millions, while also rewarding investors
with extraordinary returns. As veteran company-builders, Cardinal principals
partner with entrepreneurs, scientists, clinicians, engineers and
inventors in the challenging task of growing great companies from great
ideas. Over the course of their careers, the Cardinal Partners team has
invested in over one hundred growth companies. Since 1997 alone, companies
funded by Cardinal have a cumulative market valuation exceeding $6 Billion.
Cardinal's investors include university endowments, foundations, pension
funds, banks, and insurance companies. Cardinal currently manages funds
totaling $330 Million. For more information, visit Cardinal Partners :: Welcome




About Venrock

Venrock is a premier venture capital firm with offices in Palo Alto, New
York, Cambridge, MA, and Israel. Originally established as the venture
capital arm of the Rockefeller family, Venrock continues a seven-decade
tradition of partnering with entrepreneurs to establish successful, enduring
companies. Having invested $2.2 billion in 417 companies resulting in 124
IPOs over the past 39 years, Venrock's investment returns place it among the
top tier venture capital firms that have achieved consistently superior
performance. With a primary focus on technology, healthcare, and energy,
portfolio companies have included Adify, Adnexus Therapeutics, Apple
Computer, Centocor, Check Point Software, DoubleClick, Gilead Sciences, Idec
Pharmaceuticals, Illumina, Intel, Millennium Pharmaceuticals, Sirna
Therapeutics, StrataCom, and Vontu. For more information, please visit
Venrock's website at Venrock



About Avalon Ventures

Avalon Ventures is a San Diego-based venture capital fund focusing on seed
and early stage companies in life sciences, wireless communications and Web
3.0 digital media, primarily in California and the Northeast. The Company's
current Fund, Avalon VIII, L.P. is $150 million. Avalon Ventures is one of
the longest-standing venture capital firms in San Diego, investing in life
sciences and information technology opportunities locally and around the
country since 1983 through eight Avalon Ventures funds. The collective
market capitalization of Avalon Ventures portfolio companies (most founded
by Avalon partners) currently exceeds $11 billion. For more information,
visit Avalon Ventures